| Stage | LH | % of rev | RRX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $3.8B | 100.00% | $1.6B | 100.00% | LH ×2.44 |
| Gross profit | $1.1B | 29.08% | $612M | 39.25% | RRX +10.2pp |
| Operating income | $402M | 10.55% | $215M | 13.81% | RRX +3.3pp |
| Pre-tax income | $328M | 8.61% | $144M | 9.22% | RRX +0.6pp |
| Net income | $263M | 6.91% | $117M | 7.49% | RRX +0.6pp |
| Stage | LH | RRX | Gap · A − B |
|---|---|---|---|
| Revenue | $3.8B100.00% | $1.6B100.00% | LH ×2.44 |
| Gross profit | 29.08%$1.1B | 39.25%$612M | RRX +10.2pp |
| Operating income | 10.55%$402M | 13.81%$215M | RRX +3.3pp |
| Pre-tax income | 8.61%$328M | 9.22%$144M | RRX +0.6pp |
| Net income |
| 6.91%$263M |
| 7.49%$117M |
| RRX +0.6pp |